• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Recursion Pharmaceuticals

    Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Report Third Quarter 2024 Business Updates and Financial Results on November 6th
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    CORRECTION - Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Announces Proposed Offering of Class A Common Stock
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Participate in Upcoming Investor Conference
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Publishes Annual Environmental, Social and Governance Report
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Host Public L(earnings) Call on February 27
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Altitude Lab Startups Raise Over $120M in Capital
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Bayer and Recursion Focus Research Collaboration on Oncology
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Participate in Upcoming Investor Conference
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Tickers RXRX
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.